Successful Haploidentical Transplant Using Post-Transplant Cyclophosphamide in a Child with Chronic Granulomatous Disease-First Report from the Indian Subcontinent

J Clin Immunol. 2021 May;41(4):820-824. doi: 10.1007/s10875-020-00951-y. Epub 2021 Jan 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alleles
  • Child, Preschool
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use*
  • Genotype
  • Granulomatous Disease, Chronic / diagnosis
  • Granulomatous Disease, Chronic / genetics
  • Granulomatous Disease, Chronic / therapy*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • India
  • Male
  • Mutation
  • NADPH Oxidases / genetics
  • Postoperative Care
  • Transplantation, Haploidentical*
  • Treatment Outcome

Substances

  • Cyclophosphamide
  • NADPH Oxidases
  • neutrophil cytosolic factor 1